Literature DB >> 6801179

Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.

K A Joiner, C H Hammer, E J Brown, R J Cole, M M Frank.   

Abstract

The mechanism of resistance of gram-negative bacteria to killing by complement was investigated. Complement consumption and uptake of purified, radiolabeled complement components on bacteria was studied using a serum- sensitive and a serum-resistant strain of Salmonella minnesota. Twice as many molecules of (125)I C3 were bound per colony-forming unit (CFU) of the smooth, serum-resistant S. minnesota S218 as were bound per CFU of the rough, serum-sensitive S. minnesota Re595 in 10 percent pooled normal human serum (PNHS), although 75-80 percent of C3 was consumed by both organisms. Hemolytic titrations documented total consumption of C9 by 5 min and more than 95 percent consumption of C5 and C7 by 15 min in the reaction with S218 with 10 percent PNHS. In contrast, negligible C5 depletion, 10 percent C7 consumption, and only a 26 percent decrease in C9 titer occurred with the serum-sensitive Re595. Binding of (125)I C5, (125)I C7, and (125)I C9 to S218 and Re595 was measured in 10 percent PNHS. A total of 6,600 molecules C5/CFU, 5,200 molecules C7/CFU, and 3,100 molecules C9/CFU bound to S218 after 5-10 min of incubation at 37 degrees C, but 50-70 percent of the C5, C7, and C9 bound to S218 was released from the organism during incubation at 37 degrees C for 60 min. Binding of 2,000 molecules C5/CFU, 1,900 molecules C7/CFU, and 9,000 molecules C9/CFU to Re595 was achieved by 20 min and was stable. The ratio of bound C9 molecules to bound C7 molecules, measured using (131)I C9 and (125)I C7, was constant for both organisms after 15 min and was 4.3:1 on Re595 and 0.65:1 on S218 in 10 percent PNHS. With addition of increasing amounts of purified, unlabeled (29 to 10 percent PNHS, there was no change in the C9:C7 ratio on Re595. However, with S218 there was a linear increase of the C9:C7 ratio, which approached the ratio on Re595. There was no (14)C release from S218 incubated in PNHS, nor was there evidence by electron microscopy of outer membrane damage to S218. Therefore, S. minnesota S218 is resistant to killing by PNHS, despite the fact that the organism consumes terminal complement components efficiently and that terminal components are deposited on the surface in significant amounts. The C5b-9 complex is released from the surface of S218 without causing lethal outer membrane damage.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6801179      PMCID: PMC2186629          DOI: 10.1084/jem.155.3.797

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  A STUDY OF THE RELATIONSHIP OF THE NORMAL BACTERICIDAL ACTIVITY OF HUMAN SERUM TO BACTERIAL INFECTION.

Authors:  R J Roantree; L A Rantz
Journal:  J Clin Invest       Date:  1960-01       Impact factor: 14.808

2.  [Studies on the immune bacteriolysis. XIV. Requirement of all nine components of complement for immune bacteriolysis].

Authors:  K Inoue; K Yonemasu; A Takamizawa; T Amano
Journal:  Biken J       Date:  1968-09

Review 3.  Immunochemistry of O and R antigens of Salmonella and related Enterobacteriaceae.

Authors:  O Lüderitz; A M Staub; O Westphal
Journal:  Bacteriol Rev       Date:  1966-03

4.  Precipitating antibody against core glycolipid of Enterobacteriaceae.

Authors:  L S Young; P R Stevens
Journal:  Experientia       Date:  1974-02-15

5.  Lethal effect of complement and lysozyme on polymyxin-treated, serum-resistant gram-negative bacilli.

Authors:  J Fierer; F Finley
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

6.  Interaction of complement components with a serum-resistant strain of Salmonella typhimurium.

Authors:  B L Reynolds; U A Rother; K O Rother
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

7.  Normal serum cytotoxicity for P32-labeled smooth Enterobacteriaceae. II. Fate of macromolecular and lipid phosphorus of damaged cells.

Authors:  J K Spitznagel
Journal:  J Bacteriol       Date:  1966-01       Impact factor: 3.490

8.  Sensitivity of rough gram-negative bacteria to the bactericidal action of serum.

Authors:  D Rowley
Journal:  J Bacteriol       Date:  1968-05       Impact factor: 3.490

9.  Characterization of complement resistance in Escherichia coli conferred by the antibiotic resistance plasmid R100.

Authors:  R T Ogata; R P Levine
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

10.  Molecular analysis of the membrane attack mechanism of complement.

Authors:  W P Kolb; J A Haxby; C M Arroyave; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1972-03-01       Impact factor: 14.307

View more
  71 in total

1.  Pore formation by complement in the outer membrane of gram-negative bacteria studied with asymmetric planar lipopolysaccharide/phospholipid bilayers.

Authors:  G Schröder; K Brandenburg; L Brade; U Seydel
Journal:  J Membr Biol       Date:  1990-11       Impact factor: 1.843

2.  Phagocytosis of virulent Porphyromonas gingivalis by human polymorphonuclear leukocytes requires specific immunoglobulin G.

Authors:  C W Cutler; J R Kalmar; R R Arnold
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

3.  Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance.

Authors:  M J Blaser; P F Smith; J E Repine; K A Joiner
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

4.  Mechanism of YadA-mediated serum resistance of Yersinia enterocolitica serotype O3.

Authors:  D Pilz; T Vocke; J Heesemann; V Brade
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

5.  Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation.

Authors:  G A Jarvis; N A Vedros
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

6.  Resistance of Escherichia coli to osmotically introduced complement component C9.

Authors:  J R Dankert
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

7.  The polysaccharide portion of lipopolysaccharide regulates antigen-specific T-cell activation via effects on macrophage-mediated antigen processing.

Authors:  N M Zirk; S F Hashmi; H K Ziegler
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

8.  Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9.

Authors:  K A Joiner; M A Schmetz; M E Sanders; T G Murray; C H Hammer; R Dourmashkin; M M Frank
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

9.  Comparison of loss of serum resistance by defined lipopolysaccharide mutants and an acapsular mutant of uropathogenic Escherichia coli O75:K5.

Authors:  S M Burns; S I Hull
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

10.  The ail gene of Yersinia enterocolitica has a role in the ability of the organism to survive serum killing.

Authors:  D E Pierson; S Falkow
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.